KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Receivables (2016 - 2026)

Neogenomics filings provide 17 years of Receivables readings, the most recent being $167.4 million for Q1 2026.

  • On a quarterly basis, Receivables rose 10.72% to $167.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $167.4 million, a 10.72% increase, with the full-year FY2025 number at $159.2 million, up 5.71% from a year prior.
  • Receivables hit $167.4 million in Q1 2026 for Neogenomics, up from $159.2 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $167.4 million in Q1 2026 to a low of $112.4 million in Q1 2022.
  • Median Receivables over the past 5 years was $140.5 million (2024), compared with a mean of $138.1 million.
  • Biggest five-year swings in Receivables: increased 17.13% in 2024 and later grew 2.55% in 2025.
  • Neogenomics' Receivables stood at $121.6 million in 2022, then rose by 7.94% to $131.3 million in 2023, then rose by 14.76% to $150.6 million in 2024, then increased by 5.71% to $159.2 million in 2025, then grew by 5.14% to $167.4 million in 2026.
  • The last three reported values for Receivables were $167.4 million (Q1 2026), $159.2 million (Q4 2025), and $155.3 million (Q3 2025) per Business Quant data.